FirstMedCommsJob: Working in regulatory medical writing

Note this is a video recording of an online meeting conducted using the Zoom.us platform. Inevitably such recordings suffer a little in terms of their production values because of the internet connectivity and quality of webcams. Despite that, they allow us to provide additional valuable insights in to the MedComms business and we can involve a wider range of speakers who can participate from the comfort of their own desks, wherever in the world they are.
In this webinar, we're joined by Amy Ball and Megan Stanton-Humphreys from Insight Medical Writing, sponsors of our annual FirstMedCommsJob careers guide, "A writer's role in drug development: a guide to getting started in regulatory medical writing". The latest edition of the guide was published in September 2021. We talk about the regulatory medical writing services they provide and the different roles within their teams. You'll learn about what they look for in entry-level staff, what training is provided and the career prospects. We reflect on the differences between MedComms and regulatory medical writing activities. And we answer questions from the audience.
It should be of interest to anyone who is looking for insights in to medical writing as a career and how to maximise their chances of gaining an entry-level job.
Recorded 06 October 2021 as a MedComms Networking webinar. Produced by NetworkPharma.tv
= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
Amy's LinkedIn page is at / amy-ball
You can find our more about Insight Medical Writing at www.insightmw.com/
The latest copy of our annual careers guide, A writer's role in drug development: a guide to getting started in regulatory medical writing, published September 2021, is available at www.medcommsnetworking.com/reg...
Much more about working in MedComms can be found at FirstMedCommsJob.com
= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
We are building a library of free webcasts and other video content for the global MedComms Community and others at www.networkpharma.tv and we’d welcome your suggestions for new content.
[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at www.medcommsnetworking.com]